Latest filing published 10 Mar 2022 for Adaptive Biotechnologies Corp, €35k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lance Baldo: trading record in brief
This profile gathers the share dealings of Lance Baldo in Adaptive Biotechnologies Corp, where the filings describe the role as senior executive. The record holds 40 filings, for trades running from 6 May 2020 to 8 March 2022.
The open-market record consists of 25 sales worth €6.4M, with no purchase. Besides market trades, the filings include 1 share grant and 14 option exercises. Since January 2022: no purchases and 2 sales on the market.
The record was last updated on 10 March 2022 with an open-market sale (€35k) in Adaptive Biotechnologies Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lance Baldo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,350 shares@ US$11.4357.4% of flowCommon StockSEC:0001209191-22-018021:0
- 2,373 shares@ US$12.0142.6% of flowCommon StockSEC:0001209191-22-017401:0
2 of 2 declarations
